Bridging studies for NTI generics ensure that life-critical generic drugs like warfarin and levothyroxine are as safe and effective as their brand-name counterparts. Learn how stricter bioequivalence standards, complex study designs, and global regulations protect patient health.
Feb, 7 2026
